Bilcare's Q2 FY 2026-27 Quarterly Results

Result Summary

• Bilcare Ltd reported a 10.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 38.0%.
• Its expenses for the quarter were up by 18.5% QoQ and 21.3% YoY.
• The net profit decreased 92.9% QoQ and decreased 104.6% YoY.
• The earnings per share (EPS) of Bilcare Ltd stood at 1.75 during Q2 FY 2026-27.

Financial Statments for Q2 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Bilcare Ltd is a company that operates in the pharmaceutical packaging industry, providing packaging solutions and services. The company is known for its innovative solutions in packaging materials and technologies, catering primarily to the pharmaceutical and healthcare sectors. As of the latest available information, Bilcare Ltd focuses on ensuring the integrity and safety of medical products through its packaging solutions. The company’s portfolio includes a range of products such as blister packaging, foil laminates, and specialty films. There are no recent major developments available in the data provided, and additional information regarding specific strategic initiatives or market expansions is not available at this time.

Revenue

In the second quarter of the fiscal year 2027 (Q2FY27), Bilcare Ltd reported a total income of ₹251.96 crores. This represents an increase of 10.7% quarter-over-quarter (QoQ) from ₹227.61 crores in Q1FY27 and a significant year-over-year (YoY) growth of 38.0% compared to ₹182.52 crores in Q2FY26. The revenue growth both on a quarterly and annual basis reflects an upward trend in the company's income generation capabilities during this period. The increase in total income is indicative of Bilcare Ltd's ability to enhance its sales performance or expand its market share within the industry it operates.

Profitability

During Q2FY27, Bilcare Ltd recorded a profit before tax (PBT) of ₹1.98 crores, marking a significant decline of 86.7% from the previous quarter's PBT of ₹14.84 crores. Compared to the same quarter in the previous fiscal year (Q2FY26), where the company reported a loss before tax of ₹23.55 crores, the current quarter's results show a transition back to positive profitability. However, the profit after tax (PAT) for Q2FY27 also saw a substantial decrease of 92.9% QoQ to ₹1.07 crores from ₹14.97 crores in Q1FY27. Year-over-year, this represents a turnaround from a loss of ₹23.32 crores in Q2FY26. Despite the positive YoY improvement, the profitability metrics suggest a notable decline in quarter-on-quarter terms.

Operating Metrics

The total expenses for Bilcare Ltd in Q2FY27 amounted to ₹249.98 crores, which is an 18.5% increase from ₹211.03 crores in Q1FY27 and a 21.3% rise from ₹206.07 crores in Q2FY26. The escalation in expenses over both periods highlights an increase in operational costs. Earnings per share (EPS) for Q2FY27 stood at ₹1.75, a decrease of 67.5% QoQ from ₹5.39 in Q1FY27. This metric, however, shows a year-over-year improvement from a negative EPS of ₹-5.25 in Q2FY26, reflecting a recovery in the company's operational performance. The data does not provide specific financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio, so these cannot be calculated or analyzed for further insights.